Fan, Chris K.
Jung, Heather S.
Pang, Yasmine E.
Wang, Chia-shi https://orcid.org/0000-0001-6941-0057
Article History
Received: 18 December 2025
Revised: 16 January 2026
Accepted: 28 January 2026
First Online: 17 February 2026
Declarations
:
: Chia-shi Wang has received research support from Boehringer-Ingelheim Pharmaceuticals Inc., Genentech Inc., River 3 Renal Corporation, and Dimerix Bioscience Pty. Ltd., outside the submitted work. Chris K. Fan, Heather S. Jung, and Yasmine Pang have no financial interests to disclose. Chia-shi Wang is an unpaid member of the Kidney Disease Outcomes Quality Initiative (KDOQI) Work Group for review of the 2025 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.